Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease

By LabMedica International staff writers
Posted on 14 May 2026

Limited access to general practitioners and pathology services can delay diagnosis and monitoring for people in regional and remote communities. More...

Rapid, on-the-spot testing can shorten turnaround times and reduce travel and costs, but its effect on patient engagement is less clear. Understanding whether immediate results improve self-management is critical for chronic disease care. New findings demonstrate how point-of-care testing can enhance health literacy and patient confidence.

Flinders University (Adelaide, Australia) evaluated point-of-care testing (POCT), pathology assays performed at or near the site of care that generate results during the same visit. Examples include finger-prick blood tests that enable immediate review with a clinician rather than days later via a centralized laboratory. The analysis examined whether POCT influences health literacy, defined as the ability to access, understand, remember, and use health information in daily life.

Published in BMC Public Health, the systematic review assessed 13 studies from multiple countries and included more than 21,000 participants. Most studies focused on non-communicable diseases, particularly diabetes and cardiovascular disease. Outcomes extended beyond clinical endpoints to capture changes in patient understanding of disease, confidence in self-management, motivation for lifestyle modification, and measures such as anxiety and quality of life.

Across cohorts, POCT was associated with better understanding of conditions and increased confidence in self-management, together with greater motivation to improve diet and physical activity. Several studies reported improved medication adherence and favorable shifts in clinical markers, including reductions in long-term blood glucose among people with diabetes. Parents of children with diabetes reported higher confidence when immediate results were available, and community testing initiatives prompted participants to consider healthier choices.

The review was led by Flinders University, including the Flinders Health and Medical Research Institute’s International Center for Point-of-Care Testing. Authors noted that speed and clinical context may shape how patients engage with test results, supporting conversations that connect everyday decisions with long-term outcomes. They also called for research on equitable, scalable deployment of POCT, especially where access to traditional laboratory testing is limited.

“When people receive their results straight away and can talk through what they mean with a health professional, it changes how they engage with their health. It helps turn test results into knowledge people can actually use,” said Dr. Kelcie Miller, lead author, College of Medicine and Public Health, Flinders University.

“Point-of-care testing delivers information in a way that is immediate and meaningful. It supports conversations, builds confidence and helps people connect everyday choices with long-term health outcomes,” said Mark Shephard, Matthew Flinders Professor and Founding Director, FHMRI International Center for Point-of-Care Testing, Flinders University.

Related Links
Flinders University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Guardant Health has introduced new applications for Guardant360 Liquid, expanding the test’s capabilities for treatment selection in breast and lung cancers. (Photo courtesy of Guardant Health)

Liquid Biopsy Expands Insights Into Treatment Response and Tumor Alterations

Treatment selection in advanced breast and lung cancers can be challenging when traditional biomarkers are absent and genomic findings alone do not fully clarify which therapies may be effective.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.